Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peter J. Graham Insider Profile
4 Followers
Peter J. Graham, EVP General Counsel, Secretary at Antares Pharma, holds 188.54K shares in ADC Therapeutics (Ticker: ADCT), holds 616.61K shares in Antares Pharma (Ticker: ATRS), holds 15.00K shares in Delcath Systems (Ticker: DCTH).
Peter J. Graham Antares Pharma (ATRS)EVP General Counsel, Secretary
Antares Pharma (ATRS)
EVP General Counsel, Secretary
Not Ranked
Peter J. Graham has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Peter J. Graham holds in companies
Most Profitable Insider Trade
Stock:
Antares Pharma
(ATRS)
(ATRS)
Rating:Informative Buy
Date:Mar 23, 2016 - Mar 23, 2017
Return:+279.40%
The most profitable trade made by Peter J. Graham
Peter J. Graham's Trading History
Antares Pharma
Mar 04, 2022
―
Uninformative Buy
―
$3.45M
ADC Therapeutics
Dec 09, 2024
Chief Legal Officer
Uninformative Sell
129.76K
$375.20K
Delcath Systems
Mar 01, 2012
EVP; General Counsel
Uninformative Buy
―
$180.60K
AngioDynamics
―
Director
―
$861.09K
List of latest transactions for each holding click on a transaction to see Peter J. Graham's performance on stock
You May Also Like
Peter J. Graham insider profile FAQ
What is the percentage of profitable transactions made by Peter J. Graham?
The percentage of profitable transactions made by Peter J. Graham is ―.
What is the average return per transaction made by Peter J. Graham?
The average return per transaction made by Peter J. Graham is ―.
What stocks does Peter J. Graham hold?
Peter J. Graham holds: ATRS, ADCT, DCTH, ANGO stocks.
What was Peter J. Graham’s latest transaction?
Peter J. Graham latest transaction was an Uninformative Sell of $129.76K.
What was Peter J. Graham's most profitable transaction?
Peter J. Graham’s most profitable transaction was an Informative Buy of ATRS stock on March 23, 2016. The return on the trade was 279.40%.
What is Peter J. Graham's role in Antares Pharma?
Peter J. Graham's role in Antares Pharma is EVP General Counsel, Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.